Page last updated: 2024-10-30

lomustine and Diffuse Parenchymal Lung Disease

lomustine has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The preparatory regimen consisting of lomustine/etoposide/cyclophosphamide is active in treating patients with lymphomas."5.08A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. ( Blaschke, TF; Blume, KG; Chao, NJ; Horning, SJ; Kastrissios, H; Long, GD; Negrin, RS; Wong, RM, 1995)
"A decreased incidence of interstitial pneumonitis as well as a possible benefit in efficacy has been reported with lomustine (CCNU) compared to BCNU in the standard dose setting."2.70Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. ( Blume, KG; Chao, NS; Horning, SJ; Johnston, LJ; Long, GD; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ; Wong, RM, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, NJ1
Kastrissios, H1
Long, GD2
Negrin, RS2
Horning, SJ2
Wong, RM2
Blaschke, TF1
Blume, KG2
Stuart, MJ1
Chao, NS1
Johnston, LJ1
Shizuru, JA1
Stockerl-Goldstein, KE1

Trials

2 trials available for lomustine and Diffuse Parenchymal Lung Disease

ArticleYear
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
    Cancer, 1995, Mar-15, Volume: 75, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

1995
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2001, Volume: 7, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro

2001